Welcome to the Journal of Evaluation in Clinical Practice, a respected publication in the fields of Health Policy and Public Health, released by Wiley. With over two decades of dedicated scholarship since its inception in 1995, this journal aims to advance the standards of clinical practice through rigorous evaluation and research. Ranked in the Q2 quartile, our journal stands out in its commitment to improving healthcare systems, evidenced by its high Scopus rankings (Rank #60 in Health Policy and Rank #163 in Public Health). Although it is not an open-access platform, we provide unparalleled insights into clinical evaluation methodologies, policy impacts, and health outcomes, making it an essential resource for researchers, practitioners, and students alike. Join us as we explore significant advancements and critical discussions at the intersection of clinical evaluation and public health, shaping the future of healthcare quality and effectiveness.

INTERNATIONAL JOURNAL OF RISK & SAFETY IN MEDICINE, published by IOS Press, serves as an essential platform for advancing the understanding of risk and safety within the medical domain. With an ISSN of 0924-6479 and E-ISSN of 1878-6847, this journal has been dedicated to fostering critical discourse since its inception in 1990, reflecting a continuous commitment to the field through 2024. Positioned within the Q4 category in Health Policy and Q3 in Medicine (miscellaneous) and Public Health, Environmental and Occupational Health, the journal provides valuable insights, empirical research, and theoretical analyses that speak to the diverse challenges faced in medical safety and risk management. Although it operates under a subscription model, the journal remains a vital resource for researchers, healthcare professionals, and students alike, facilitating the exchange of innovative ideas and best practices in health risk assessment. With Scopus ranks indicating its role as a key contributor in its categories, the INTERNATIONAL JOURNAL OF RISK & SAFETY IN MEDICINE continues to shape the landscape of medical safety and policy discussions around the globe.

Drug Healthcare and Patient Safety is a premier Open Access journal, published by DOVE MEDICAL PRESS LTD since 2009, dedicated to advancing the understanding and practices surrounding medication safety and healthcare delivery. With its ISSN 1179-1365 and E-ISSN matching, this New Zealand-based journal not only fosters global discourse but also prioritizes the dissemination of research that intersects both health policy and pharmacology. Categorized as Q2 in Health Policy and Q3 in Pharmacology for the year 2023, it occupies a notable position within the academic community, as reflected by its Scopus rankings, which place it in the 66th and 45th percentiles of its respective categories. Drug Healthcare and Patient Safety aims to provide a platform for researchers, practitioners, and students to share innovative findings, promote safe medication practices, and explore the implications of health policy on patient outcomes. As an Open Access journal, it ensures that vital research is accessible to a wider audience, making significant contributions to the ongoing dialogue in the fields of healthcare and pharmacovigilance.

The Journal of Health Organization and Management, published by Emerald Group Publishing Ltd, serves as a pivotal resource for professionals, researchers, and students interested in the intersection of health policy and organizational effectiveness. With an ISSN of 1477-7266 and an E-ISSN of 1758-7247, this esteemed journal has been charting advancements in health management since 2003, showcasing articles that reflect rigorous research and the latest trends in the field. Hailing from the United Kingdom, the journal has established itself within the upper echelons of academic literature, currently enjoying a Q2 classification in notable categories, including Business, Management, and Accounting, Health Policy, and Organizational Behavior and Human Resource Management, as of 2023. With impressive rankings in Scopus, including a percentile rank in the 62nd for Business and Management, it is an essential platform for disseminating innovative ideas and evidence-based findings crucial for enhancing health care systems globally. While it operates under a conventional access model, the journal remains dedicated to fostering scholarly dialogue and advancing the understanding of health organization complexities.

Journal of Patient Safety and Risk Management, published by SAGE Publications Ltd, stands as a vital resource for the exploration and discourse surrounding safety and risk in healthcare environments. Established in 2018 and continuing through 2024, this journal delivers a rich repository of knowledge aimed at improving patient safety protocols and mitigating risks within healthcare systems. With an ISSN of 2516-0435 and an E-ISSN of 2516-0443, the journal is indexed in several categories with a notable performance in Health Policy and Health (social science), rated in Q3, while also addressing Leadership and Management in Q4. Despite the absence of an open access model, the journal provides a platform for researchers, healthcare professionals, and students to stay informed about the latest developments and evidence-based practices within the dynamically evolving landscape of patient safety. Given its Scopus rankings, which include a percentile of 46th in Health (social science) and 36th in Health Policy, the journal is positioned as a credible and impactful publication for those dedicated to enhancing patient care through robust risk management strategies.

Journal of Pharmaceutical Policy and Practice, published by Taylor & Francis Ltd, is a premier open access journal dedicated to advancing the field of pharmaceutical policy and practice. Launched in 2013, this esteemed journal has rapidly become a vital resource for researchers, practitioners, and policymakers alike, offering a critical examination of health policies and their implementation in pharmaceutical contexts. With an impressive impact factor reflecting its significance, it ranks in the Q2 category for Health Policy and Q1 in both Pharmacology, Toxicology and Pharmaceutics and Pharmacy, showcasing its high-quality contributions to the field. Accessible to a global audience since 2014, the journal disseminates innovative research findings that inform best practices, foster policy development, and enhance patient outcomes in the pharmaceutical landscape. Positioned in the UK and with strong Scopus rankings, specifically ranked #3 in Health Professions (Pharmacy), the journal serves as an essential platform for those striving to navigate the ever-evolving intersection of healthcare and pharmaceutical sciences.

Introducing the JAMA Health Forum, a premier journal published by the American Medical Association, dedicated to advancing knowledge in the critical fields of health policy and public health. Since its inception in 2020, this open-access journal has emerged as a leading platform for high-quality research, achieving a distinguished Q1 ranking in both Health Policy and Public Health, Environmental and Occupational Health for 2023. With an ISSN of 2689-0186, it provides a vital resource for researchers, policymakers, and students alike, facilitating widespread dissemination of impactful studies that aim to shape health strategies and improve community health outcomes. The JAMA Health Forum not only fosters collaboration among experts but also enhances global discussions on pressing health issues, making it an essential read for anyone involved in health-related research and practice.

Northern Clinics of Istanbul is an esteemed open-access journal dedicated to advancing knowledge within the field of medicine, specifically focusing on miscellaneous areas of general medicine. Published by KARE PUBL since 2014, it provides a vital platform for researchers, healthcare professionals, and students to share innovative findings and foster academic dialogue. With its ISSN 2148-4902 and E-ISSN 2536-4553, the journal has garnered attention in the academic community, earning a reputable Q4 quartile ranking in the category of Medicine (Miscellaneous) for the year 2023 and a Scopus rank of #497 out of 636. Based in Istanbul, Turkey, the journal is committed to accessibility and relevance, making significant contributions to the global medical discourse. Northern Clinics of Istanbul aims to serve as an interdisciplinary hub for innovative research, promoting the dissemination of knowledge and enhancing collaborative efforts among scholars. Join us in exploring the latest insights that are shaping healthcare today.

The Journal of Korean Academy of Nursing, published by the Korean Society of Nursing Science, is a leading peer-reviewed journal dedicated to advancing the field of nursing research and practice. Established in 2008, this journal serves as a platform for innovative studies and discussions that address the challenges and developments in nursing. With an impressive 2023 category quartile ranking of Q2 in the field of Nursing and General Nursing, it ranks #58 out of 139 journals, placing it in the 58th percentile—a testament to its scholarly impact. Focused primarily on the nuances of nursing in South Korea and beyond, the journal fosters collaboration among various healthcare professionals and researchers, striving to improve nursing practices through empirical research and evidence-based insights. The journal is accessible to those seeking to engage with the latest findings and trends in nursing, further solidifying its role as an essential resource for researchers, practitioners, and students alike. For access and further details, please refer to the journal's homepage.

Revista del Cuerpo Medico del Hospital Nacional Almanzor Aguinaga Asenjo is a prominent medical journal published by the renowned Hospital Nacional Almanzor Aguinaga Asenjo in Peru. With the ISSN 2225-5109 and E-ISSN 2227-4731, this open-access journal has been serving the medical community since its inception in 2019. It aims to disseminate vital research and insights in the fields of health and medicine, providing a platform for the exchange of knowledge on critical issues affecting public health and healthcare policy in Latin America. Although classified in the Q4 category for both Health (social science) and Medicine (miscellaneous) in 2023, its essential contributions to health professions and policy add significant value to researchers and practitioners alike. Positioned within the context of a rapidly evolving healthcare landscape, the journal is crucial for fostering a better understanding of the challenges and innovations in healthcare delivery and medical practice. Researchers, professionals, and students looking to deepen their understanding of these fields will find this journal invaluable as it continues to grow and adapt through 2024 and beyond.